参考文献/References:
[1] 国家癌症中心,国家肿瘤质控中心膀胱癌质控专家委员会.中国膀胱癌规范诊疗质量控制指标(2022版)[J].中华肿瘤杂志,2022,44(10):1003-1010.
[2] 陈思婷,魏媛,斯热努尔·艾合买提,等.吉西他滨联合顺铂新辅助化疗在肌层浸润性膀胱癌中的疗效分析[J].实用肿瘤杂志,2022,37(5):457-464.
[3] BULLOCK A J,HOFSTATTER E W,YUSHAK M L,et al.Understanding patients' attitudes toward communication about the cost of cancer care[J].J Oncol Pract,2012,8(4):e50-e58.
[4] ZAFAR S Y,ABERNETHY A P.Financial toxicity,part Ⅰ:a new name for a growing problem[J].Oncology(Williston Park),2013,27(2):80-81,149.
[5] BHANVADIA S K.Bladder cancer survivorship[J/OL].[2023-07-20].https://link.springer.com/article/10.1007/s11934-018-0860-6.DOI:10.1007/s11934-018-0860-6.
[6] 周溢,杨丽,张妍欣,等.鼻咽癌幸存者经济毒性现状及影响因素分析[J].军事护理,2023,40(1):15-18.
[7] DE SOUZA J A,YAP B J,HLUBOCKY F J,et al.The development of a financial toxicity patient-reported outcome in cancer:the COST measure[J].Cancer,2014,120(20):3245-3253.
[8] 于慧会,毕雪,刘运泳.中文版癌症患者报告结局的经济毒性量表信度和效度研究[J].中华流行病学杂志,2017,38(8):1118-1120.
[9] CONNOR K M,DAVIDSON J R T.Development of a new resilience scale:the connor-davidson resilience scale(CD-RISC)[J].Depress Anxiety,2003,18(2):76-82.
[10]于肖楠,张建新.自我韧性量表与Connor-Davidson韧性量表的应用比较[J].心理科学,2007,30(5):1169-1171.
[11]ZIMET G D,POWELL S S,FARLEY G K,et al.Psychometric characteristics of the multidimensional scale of perceived social support[J].J Pers Assess,1990,55(3-4):610-617.
[12]姜乾金.领悟社会支持量表[J].中国行为医学科学,2001,10(10):41-43.
[13]BHANVADIA S K,PSUTKA S P,BURG M L,et al.Financial toxicity among patients with prostate,bladder,and kidney cancer:a systematic review and call to action[J].Eur Urol Oncol,2021,4(3):396-404.
[14]HAZELL S Z,FU W,HU C,et al.Financial toxicity in lung cancer:an assessment of magnitude,perception,and impact on quality of life[J].Ann Oncol,2020,31(1):96-102.
[15]RIPAMONTI C I,CHIESI F,DI PEDE P,et al.The validation of the Italian version of the comprehensive score for financial toxicity(COST)[J].Support Care Cancer,2020,28(9):4477-4485.
[16]NGUYEN N H,KHERA R,OHON-MACHADO L,et al.Prevalence and effects of food insecurity and social support on financial toxicity in and healthcare use by patients with inflammatory bowel diseases[J].Clin Gastroenterol Hepatol,2021,19(7):1377-1386.
相似文献/References:
[1]刘玉芹,杨明莹,李丹娜,等.膀胱癌特异性患者报告结局测量工具的研究进展[J].军事护理,2021,38(06):62.[doi:10.3969/j.issn.1008-9993.2021.06.016]
[2]汪红姣,王颖,吴梅利洋,等.膀胱癌患者尿流改道术式决策冲突现状及影响因素分析[J].军事护理,2023,40(09):60.[doi:10.3969/j.issn.2097-1826.2023.09.015]
WANG Hongjiao,WANG Ying,WU Meiliyang,et al.Status Quo of Decision Conflicts Among Bladder Cancer Patients with Urinary Diversion and Its Influencing Factors[J].Nursing Journal Of Chinese People's Laberation Army,2023,40(12):60.[doi:10.3969/j.issn.2097-1826.2023.09.015]